# BYSANTI
> **NDA220358** · New Drug Application · Sponsor: VANDA PHARMS INC · Approved 2026-02-20
## Drug
- **FDA Application Number:** NDA220358
- **Application type:** New Drug Application
- **Brand name:** BYSANTI
- **Generic name:** Milsaperidone
- **Active ingredients:** MILSAPERIDONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** VANDA PHARMS INC
- **First approval:** 2026-02-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220358)
---
*AI Analytics · CC0 1.0*